STEVANATO GROUP SPA (STVN) Stock News

Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025

Tesla, Apple, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Mentions: AAPL CECO NTES NVDA ...

Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Mentions: NMAX GIC ADPT IIIN ...

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024

Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025

Stevanato Group to Present at Upcoming Investor Conference

Stevanato Group to Present at Upcoming Investor Conferences

Stevanato Group Reports Financial Results for the Third Quarter of 2024

Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024

Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan

Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”

Stevanato Group to Present at Upcoming Investor Conferences

STVN Stock Earnings: Stevanato Gr Misses EPS, Beats Revenue for Q2 2024

STVN stock results show that Stevanato Gr missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Stevanato Group Reports Financial Results for the Second Quarter of 2024

Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024

Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges

Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro

Stevanato Group Announces Results of Annual General Meeting

Stevanato Group to Present at Upcoming Investor Conferences

STVN Stock Earnings: Stevanato Gr Misses EPS, Beats Revenue for Q1 2024

STVN stock results show that Stevanato Gr missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Stevanato Group Reports Financial Results for the First Quarter of 2024

Stevanato Group to Present at the Bank of America Securities Healthcare Conference

Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024

Italy’s Frugal Pharma Billionaire Eyes Place Among Global Leaders in Drug Injection Devices

If you got a Covid or flu shot this winter, the vaccine may well have come out of a vial made by Stevanato Group SpA, one of just a handful of Italian firms listed on the New York Stock Exchange.